Does the endothelial function change in renal transplant patients with longer duration of exposure and with higher cumulative doses of cyclosporine?

Transplantation Proceedings

Volumn 36, Issue 5, 2004, Pages 1361-1366

  Mercanoglu, F ^a   Oflaz, H ^a   Turkmen, A ^a   Kocaman, O ^a   Bunyak, B ^a   Umman, S ^a   Yekeler, E ^b   Kasikcioglu, E ^b   Meric, M ^a   Demirel, S ^a   Kucuk, M ^a   Sever, M S ^a  

^a Nephrology ^*  (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; ISOSORBIDE DINITRATE;

ADULT; ARTERY DIAMETER; ARTICLE; BRACHIAL ARTERY; CHEMICAL ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DRUG EXPOSURE; DRUG MEGADOSE; ENDOTHELIUM; FEMALE; HUMAN; HYPEREMIA; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; ULTRASOUND; UREMIA; VASODILATATION;

ADULT; BLOOD UREA NITROGEN; CYCLOSPORINE; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; REFERENCE VALUES; REGRESSION ANALYSIS; TIME FACTORS; UREMIA; VASODILATION;

EID: 20844438355     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.05.053     Document Type: Article

References (33)

1. Ovuworie C.A., Fox R.E., Chow C., et al. Vascular endothelial function in cyclosporine and tacrolimus treated renal transplant recipients. Transplantation. 72:2001;1385
2. Calo L., Semplicini A., Davis P.A., et al. Cyclosporin-induced endothelial dysfunction and hypertension are nitric oxide system abnormality and oxidative stress involved. Transpl Int. 13:2000;413
3. Morris S.T.W., McMurrey J.J.Y., Rodger R.S.C., et al. Endothelial dysfunction in renal transplant recipients maintained on cyclosporine. Kidney Int. 57:2000;1100
4. Gallego M.J., Garcia Villanlon A.L., Lopez Farre A.J. Mechanism of endothelial cell toxicity of cyclosporine A role of nitric oxide, cGMP and calcium. Cir Res. 74:1994;477
5. Celermajer D.C., Sorenson K.E., Gooch V.M., et al. Non invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 340:1992;1111
6. Hausberg M., Kisters K., Kosch M., et al. Flow mediated vasodilation and distensibility of the brachial artery in renal allograft recipients. Kidney Int. 55:1999;1104
7. Annuk M., Lind L., Linde T., et al. Impaired endothelium dependent vasodilation in renal failure in humans. Nephrol Dial Transplant. 16:2001;302
8. Anderson T.J., Uehata A., Gerhard M.D. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 26:1995;1235
9. Takase B., Uehata A., Akima T., et al. Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease. Am J Cardiol. 82:1998;1535
10. Diederich D., Skopec J., Diederich A., et al. Cyclosporine produces endothelial dysfunction by increased production of superoxide. Hypertension. 23:1994;957
11. Cartier R., Dagenais F., Hollmann C., et al. Chronic exposure to cyclosporine affects endothelial and smooth muscle reactivity in the rat aorta. Ann Thorac Surg. 58:1994;789
12. Calo L., Semplicini A., Davis P.A., et al. Cyclosporine induced endothelial dysfunction and hypertension are nitric oxide system abnormality and oxidative stress involved. Transplant Int. 13:(Suppl 1):2000;413
13. Bracht C., Yan X.W., Larocco H.P.B., et al. Cyclosporine A and control of vascular tone in the human forearm, influence of posttransplant hypertension. Hypertens. 17:1999;357
14. Iiyama K., Nagano M., Yo Y., et al. Impaired endothelial function with essential hypertension assessed by ultrasonography. Am Heart J. 132:1996;779
15. Aakhus S., Dahl K., Wideroe T.E. Cardiovascular morbidity and risk factors in renal transplant patients. Nephrol Dial Transplant. 54:1999;648
16. Vaziri N.D., Ismail M., Martin D.C., et al. Blood coagulation, fibrinolytic and inhibitory profiles in renal transplant recipients comparison of cyclosporine and azathioprine. Int J Artif Organs. 15:1992;365
17. Hunt B.J., Segal H., Yacoup M. Hemostatic changes in heart transplant recipients and their relationship to accelerated coronary sclerosis. Transplantation. 55:1993;309
18. Malyszko J., Malyszko J.S., Pawlak K., et al. The coagulolytic system and endothelial function in cyclosporine treated kidney allograft recipients. Transplantation. 62:1992;828
19. Koc M., Bihorac A., Segal M.S. Circulating endothelial cells as potential markers of the state of the endothelium in hemodialysis patients. Am J Kidney Dis. 42:2003;704
20. Navarro-Antolin J., Rey-Campos J., Lamas S. Transcriptional induction of endothelial nitric oxide gene by cyclosporine A. A role for activator protein-1. J Biol Chem. 275:2000;3075
21. Calo L., Giacon B., Davis P.A., et al. Oxidative stress and TGF beta in kidney-transplanted patients with cyclosporine-induced hypertension. Effect of carvedilol and nifedipine. Clin Nephrol. 58:2002;103
22. Amore A., Emancipator S.N., Cirina P., et al. Nitric oxide mediates cyclosporine-induced apoptosis in cultured renal cells. Kidney Int. 57:2000;1549
23. Stroes E.S., Luscher T.F., de Groot F.G., et al. Cyclosporine A increases nitric oxide activity in vivo. Hypertension. 29:1997;570
24. Wilkinson I.B., Qasem A., McEniry C.M., et al. Nitric oxide regulates local arterial distensibility in vivo. Circulation. 105:2002;213
25. Pannier B., Guerin A.P., Marchais S.J., et al. Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease. Kidney Int. 57:2000;1091
26. Hausberg M., Kisters K., Kosch M., et al. Flow-mediated vasodilation and distensibility of the brachial artery in renal allograft recipients. Kidney Int. 55:1999;1104
27. London G.M., Druecke T.B. Atherosclerosis and arterioscle-rosis in chronic renal failure. Kidney Int. 51:1997;1678
28. Suwelack B., Witta J., Hausberg M., et al. Studies on structural changes of the carotid arteries and the heart in asymptomatic renal transplant recipients. Nephrol Dial Transplant. 14:1999;160
29. Koenigs C.J., Dammers R., Rensma P.L., et al. Arterial wall properties in patients with renal failure. Am J Kidney Dis. 39:2002;1206
30. Kasiske B.L., Guijarro C., Massy Z.A., et al. Cardiovascular disease after renal transplantation. J Am Soc Nephrol. 7:1996;158
31. Anderson T.J., Elstein E., Haber H., et al. Comparative study of ACE inhibition, angiotensin II antagonism, and calcium channel blockade on flow mediated vasodilation in patients with coronary disease. J Am Coll Cardiol. 35:2000;60
32. Stevinkel P. Endothelial dysfunction and inflammation - is there a link. Nephrol Dial Transplant. 16:2001;1968
33. Zoccali C., Bendetto F.A., Mallamaci F., et al. Inflammation is associated with carotid atherosclerosis in dialysis patients, creed investigators. Cardiovascular risk extended evaluation in dialysis patients. J Hypertens. 18:2000;1207